Success Stories: An Assistant Scientist from India Secures EB1A approval Despite a Long Wait with Our Reliable Team’s Assistance
Client’s Testimonial:
“I am amongst the many scientists who contacted Chen Imm. for the petition. I am glad that the case preparation has been completed. Chen Imm. provided me with templates and forms that helped me to organize and complete the submission on time. Without their templates and updates, I doubt that I could not have done my GC preparation during my busy schedule at work. I gave a 5-star for the service provided and will highly recommend my network. Thanks again!”
On May 19th, 2022, we received another EB-1A (Alien of Extraordinary Ability) approval for an Assistant Scientist in the Field of Infectious Diseases (Approval Notice).
General Field: Infectious Diseases
Position at the Time of Case Filing: Assistant Scientist
Country of Origin: India
State of Residence at the Time of Filing: Georgia
Approval Notice Date: May 19th, 2022
Processing Time: 16 months, 5 days
Case Summary:
Our client, an assistant scientist, has made foremost contributions of major significance to the field of infectious diseases to understand the host immunology during tuberculosis and test the efficacy of novel vaccines as protection against tuberculosis. When he hired the North America Immigration Law Group to help him file an EB-1A (Alien of Extraordinary Ability) petition, we asked him to mail us the package of his credentials. After we evaluated his noteworthy research focus on the efficacy of tuberculosis vaccines, crosstalk in tuberculosis, and the role of myeloid derived suppressor cells in the spread of tuberculosis, therefore, we were certain that his research addresses some of our nation’s and the world’s most pressing issues, including methods to combat this disease, which is a threat to public health around the globe.
When we agreed to file his EB1A petition, we intended to emphasize a strong case on his behalf by including his remarkable research background and his numerous research achievements, and prove that he will undoubtedly continue to make critical discoveries that positively affect human health.
This I-140 petition package consisted of the following details:
- He held a Ph.D. in tuberculosis and host-pathogen interaction where his work has resulted in 9 peer-reviewed scientific articles, which altogether accumulated 390 citations from other experts in the field in at least 43 countries. These citations are only a few of the available examples, but they are sufficient to demonstrate his high standing in the field.
- Furthermore, we specified that his contributions to the field cannot be claimed by any other researcher. With his pioneering accomplishments, he conducted 70 peer reviews, confirming that his knowledge and experience in the field are of great significance to treating one of the deadliest infectious diseases in the world, and the field cannot afford to lose his perspective and talent.
“The main focus of his work is the discovery and development of cutting-edge therapeutic interventions for tuberculosis. Eliminating tuberculosis in the United States will require new forms of intervention with the capability to effectively target these multi-drug-resistant variants. Therefore, [client] is applying his many years of expertise in infectious disease research to develop new approaches to overcome these challenges. His work has substantial implications for Americans' wellbeing and undoubtedly warrants support.”
Successfully, our client achieved his EB-1A petition approval despite a long wait. We are glad that he did not receive any RFE (Request for Additional Evidence) and that his case was adjudicated thoroughly. We sincerely thank him for putting his faith in our law firm and allowing us to be an integral part of this victorious story.